The Traderszone Network

Published in TZ Latest News 10 November, 2015 by The TZ Newswire Staff

Citron’s Left: Mallinckrodt ‘worse’ than Valeant

The head of short-selling firm Citron Research called for more disclosures about the effectiveness of Mallinckrodt’s main drug on Tuesday.